{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:07:01Z","timestamp":1773356821269,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sukoyaka Grant for Maternal and Child Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10157-022-02238-5","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T14:08:37Z","timestamp":1653487717000},"page":"1014-1021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2727-2906","authenticated-orcid":false,"given":"Natsumi","family":"Yamamura-Miyazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimi","family":"Michigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Ozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsusuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Hasuike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"2238_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-physiol-021119-034650","volume":"82","author":"J Musgrove","year":"2020","unstructured":"Musgrove J, Wolf M. Regulation and effects of FGF23 in chronic kidney disease. Annu Rev Physiol. 2020;82:365\u201390.","journal-title":"Annu Rev Physiol"},{"key":"2238_CR2","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1152\/physrev.00022.2017","volume":"98","author":"T Michigami","year":"2018","unstructured":"Michigami T, Kawai M, Yamazaki M, Ozono K. Phosphate as a signaling molecule and its sensing mechanism. Physiol Rev. 2018;98:2317\u201348.","journal-title":"Physiol Rev"},{"key":"2238_CR3","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79:1370\u20138.","journal-title":"Kidney Int"},{"key":"2238_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Guti\u00e9rrez","year":"2008","unstructured":"Guti\u00e9rrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, J\u00fcppner H, Wolf M. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359:584\u201392.","journal-title":"N Engl J Med"},{"key":"2238_CR5","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.2215\/CJN.02110216","volume":"11","author":"AA Portale","year":"2016","unstructured":"Portale AA, Wolf MS, Messinger S, Perwad F, Juppner H, Warady BA, Furth SL, Salusky IB. Fibroblast growth factor 23 and risk of CKD progression in children. Clin J Am Soc Nephrol. 2016;11:1989\u201398.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2238_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.kint.2016.10.021","volume":"91","author":"J Munoz Mendoza","year":"2017","unstructured":"Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, Lash JP, Chen J, He J, Navaneethan S, Negrea L, Rosas SE, Kretzler M, Nessel L, Xie D, Anderson AH, Raj DS, Wolf M. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease. Kidney Int. 2017;91:711\u20139.","journal-title":"Kidney Int"},{"key":"2238_CR7","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.kint.2019.04.009","volume":"96","author":"D Egli-Spichtig","year":"2019","unstructured":"Egli-Spichtig D, Imenez Silva PH, Glaudemans B, Gehring N, Bettoni C, Zhang MYH, Pastor-Arroyo EM, Schonenberger D, Rajski M, Hoogewijs D, Knauf F, Misselwitz B, Frey-Wagner I, Rogler G, Ackermann D, Ponte B, Pruijm M, Leichtle A, Fiedler GM, Bochud M, Ballotta V, Hofmann S, Perwad F, Foller M, Lang F, Wenger RH, Frew I, Wagner CA. Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation. Kidney Int. 2019;96:890\u2013905.","journal-title":"Kidney Int"},{"key":"2238_CR8","first-page":"17","volume":"17","author":"A Gohil","year":"2019","unstructured":"Gohil A, Imel EA. FGF23 and associated disorders of phosphate wasting. Pediatr Endocrinol Rev. 2019;17:17\u201334.","journal-title":"Pediatr Endocrinol Rev"},{"key":"2238_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jdiacomp.2013.09.004","volume":"28","author":"JS Garland","year":"2014","unstructured":"Garland JS, Holden RM, Ross R, Adams MA, Nolan RL, Hopman WM, Morton AR. Insulin resistance is associated with fibroblast growth factor-23 in stage 3\u20135 chronic kidney disease patients. J Diabetes Complications. 2014;28:61\u20135.","journal-title":"J Diabetes Complications"},{"key":"2238_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11892-020-01335-7","volume":"20","author":"SMH Yeung","year":"2020","unstructured":"Yeung SMH, Bakker SJL, Laverman GD, De Borst MH. Fibroblast growth factor 23 and adverse clinical outcomes in type 2 diabetes: a bitter-sweet symphony. Curr Diab Rep. 2020;20:50.","journal-title":"Curr Diab Rep"},{"key":"2238_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fimmu.2018.00586","volume":"9","author":"IM Rea","year":"2018","unstructured":"Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol. 2018;9:586.","journal-title":"Front Immunol"},{"key":"2238_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s10157-013-0856-y","volume":"18","author":"O Uemura","year":"2014","unstructured":"Uemura O, Nagai T, Ishikura K, Ito S, Hataya H, Gotoh Y, Fujita N, Akioka Y, Kaneko T, Honda M. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18:626\u201333.","journal-title":"Clin Exp Nephrol"},{"key":"2238_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ki.2013.444","volume":"85","author":"A Levin","year":"2014","unstructured":"Levin A, Stevens PE. Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014;85:49\u201361.","journal-title":"Kidney Int"},{"key":"2238_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/0004563213510708","volume":"51","author":"ER Smith","year":"2014","unstructured":"Smith ER, McMahon LP, Holt SG. Fibroblast growth factor 23. Ann Clin Biochem. 2014;51:203\u201327.","journal-title":"Ann Clin Biochem"},{"key":"2238_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/ndt\/gft456","volume":"29","author":"A Bouma-de Krijger","year":"2014","unstructured":"Bouma-de Krijger A, Bots ML, Vervloet MG, Blankestijn PJ, Ter Wee PW, van Zuilen AD, Wetzels JF. Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease. Nephrol Dial Transplant. 2014;29:88\u201397.","journal-title":"Nephrol Dial Transplant"},{"key":"2238_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266\u201381.","journal-title":"N Engl J Med"},{"key":"2238_CR17","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E W\u00fchl","year":"2009","unstructured":"W\u00fchl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, M\u00f6ller K, Wigger M, Peruzzi L, Mehls O, Schaefer F. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361:1639\u201350.","journal-title":"N Engl J Med"},{"key":"2238_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/ki.2010.107","volume":"78","author":"M van Husen","year":"2010","unstructured":"van Husen M, Fischer AK, Lehnhardt A, Klaassen I, M\u00f6ller K, M\u00fcller-Wiefel DE, Kemper MJ. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney Int. 2010;78:200\u20136.","journal-title":"Kidney Int"},{"key":"2238_CR19","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1093\/ndt\/gfs109","volume":"27","author":"MD Sinha","year":"2012","unstructured":"Sinha MD, Turner C, Dalton RN, Rasmussen P, Waller S, Booth CJ, Goldsmith DJ. Investigating FGF-23 concentrations and its relationship with declining renal function in paediatric patients with pre-dialysis CKD Stages 3\u20135. Nephrol Dial Transplant. 2012;27:4361\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"2238_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ajh\/hpy154","volume":"32","author":"B Czaya","year":"2019","unstructured":"Czaya B, Seeherunvong W, Singh S, Yanucil C, Ruiz P, Quiroz Y, Grabner A, Katsoufis C, Swaminathan S, Abitbol C, Rodriguez-Iturbe B, Faul C, Freundlich M. Cardioprotective effects of paricalcitol alone and in combination with FGF23 receptor inhibition in chronic renal failure: experimental and clinical studies. Am J Hypertens. 2019;32:34\u201344.","journal-title":"Am J Hypertens"},{"key":"2238_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2215\/CJN.03020707","volume":"3","author":"JJ Fadrowski","year":"2008","unstructured":"Fadrowski JJ, Pierce CB, Cole SR, Moxey-Mims M, Warady BA, Furth SL. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol. 2008;3:457\u201362.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2238_CR22","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1038\/s41598-018-25439-z","volume":"8","author":"KH Nam","year":"2018","unstructured":"Nam KH, Kim H, An SY, Lee M, Cha MU, Park JT, Yoo TH, Lee KB, Kim YH, Sung SA, Lee J, Kang SW, Choi KH, Ahn C, Han SH. Circulating fibroblast growth factor-23 levels are associated with an increased risk of anemia development in patients with nondialysis chronic kidney disease. Sci Rep. 2018;8:7294.","journal-title":"Sci Rep"},{"key":"2238_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.mnh.0000447020.74593.6f","volume":"23","author":"M Wolf","year":"2014","unstructured":"Wolf M, White KE. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease. Curr Opin Nephrol Hypertens. 2014;23:411\u20139.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2238_CR24","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00467-020-04846-3","volume":"36","author":"K Meza","year":"2021","unstructured":"Meza K, Biswas S, Zhu YS, Gajjar A, Perelstein E, Kumar J, Akchurin O. Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease. Pediatr Nephrol. 2021;36:1579\u201387.","journal-title":"Pediatr Nephrol"},{"key":"2238_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00467-009-1427-z","volume":"25","author":"WW Cheung","year":"2010","unstructured":"Cheung WW, Paik KH, Mak RH. Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol. 2010;25:711\u201324.","journal-title":"Pediatr Nephrol"},{"key":"2238_CR26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00467-017-3684-6","volume":"33","author":"EA Oliveira","year":"2018","unstructured":"Oliveira EA, Cheung WW, Toma KG, Mak RH. Muscle wasting in chronic kidney disease. Pediatr Nephrol. 2018;33:789\u201398.","journal-title":"Pediatr Nephrol"},{"key":"2238_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/ndt\/gfs411","volume":"28","author":"M Wan","year":"2013","unstructured":"Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease. Nephrol Dial Transplant. 2013;28:153\u201361.","journal-title":"Nephrol Dial Transplant"},{"key":"2238_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/ckj\/sfu074","volume":"7","author":"FJ Cano","year":"2014","unstructured":"Cano FJ, Freundlich M, Ceballos ML, Rojo AP, Azocar MA, Delgado IO, Ibacache MJ, Delucchi MA, Lillo AM, Irarr\u00e1zabal CE, Ugarte MF. Longitudinal FGF23 and Klotho axis characterization in children treated with chronic peritoneal dialysis. Clin Kidney J. 2014;7:457\u201363.","journal-title":"Clin Kidney J"},{"key":"2238_CR29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1681\/ASN.2017070772","volume":"29","author":"T Isakova","year":"2018","unstructured":"Isakova T, Cai X, Lee J, Xie D, Wang X, Mehta R, Allen NB, Scialla JJ, Pencina MJ, Anderson AH, Talierco J, Chen J, Fischer MJ, Steigerwalt SP, Leonard MB, Hsu CY, de Boer IH, Kusek JW, Feldman HI, Wolf M. Longitudinal FGF23 trajectories and mortality in patients with CKD. J Am Soc Nephrol. 2018;29:579\u201390.","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02238-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-022-02238-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02238-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T22:02:43Z","timestamp":1663365763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-022-02238-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["2238"],"URL":"https:\/\/doi.org\/10.1007\/s10157-022-02238-5","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflicts of interest concerning the present study. Toshimi Michigami and Keiichi Ozono have received honorarium for lecture from Kyowa Kirin Co., Ltd. The other authors have no potential conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Boards of Osaka Women\u2019s and Children\u2019s Hospital (No. 1012) and the Hyogo College of Medicine (No. 2815), and was registered at the University Hospital Medical Information Network in Japan with the identifier UMIN000033064 on August 29, 2017.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all parents included in the study, along with assent from children where appropriate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}